Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Assets (2016 - 2025)

Iradimed (IRMD) has disclosed Current Assets for 13 consecutive years, with $84.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets rose 14.31% to $84.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $84.9 million, a 14.31% increase, with the full-year FY2024 number at $75.2 million, down 1.0% from a year prior.
  • Current Assets was $84.9 million for Q3 2025 at Iradimed, up from $77.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $84.9 million in Q3 2025 to a low of $61.3 million in Q1 2023.
  • A 5-year average of $72.3 million and a median of $71.9 million in 2023 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: grew 19.63% in 2021, then decreased 6.44% in 2023.
  • Iradimed's Current Assets stood at $76.2 million in 2021, then increased by 1.63% to $77.5 million in 2022, then fell by 1.92% to $76.0 million in 2023, then decreased by 1.0% to $75.2 million in 2024, then rose by 12.86% to $84.9 million in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Current Assets are $84.9 million (Q3 2025), $77.4 million (Q2 2025), and $75.1 million (Q1 2025).